ESR2 and breast carcinoma: The two most up-regulated AR responsive genes FADS1 and KRT19 are likely to be targets of both AR and ERβ, where FADS1 has been shown to be regulated by estrogen [26], and KRT19 expression correlating to estrogen receptor expressing breast cancer [27].